ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

TNXP Tonix Pharmaceuticals Holding Corporation

0.17
0.01005 (6.28%)
Apr 26 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Tonix Pharmaceuticals Holding Corporation TNXP NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.01005 6.28% 0.17 18:50:13
Open Price Low Price High Price Close Price Previous Close
0.16 0.1597 0.1703 0.1685 0.15995
more quote information »

Recent News

Date Time Source Heading
4/24/202407:00GLOBETonix Pharmaceuticals Announces Presentation at Planet..
4/01/202415:15GLOBETonix Pharmaceuticals Reports Fourth Quarter and Full Year..
3/28/202408:32GLOBETonix Pharmaceuticals Announces Pricing of $4.4 Million..
3/25/202407:00GLOBETonix Pharmaceuticals Receives Rare Pediatric Disease..
3/21/202407:00GLOBETonix Pharmaceuticals Announces Poster Presentation..
3/20/202407:00GLOBETonix Pharmaceuticals Announces Selection of Two Contract..
3/19/202407:00GLOBETonix Pharmaceuticals Announces Transition to Fully..
3/12/202407:00GLOBETonix Pharmaceuticals Announces Presentation at BIO-Europe..
3/11/202407:05EDGAR2Form 8-K - Current report
3/11/202407:00GLOBETonix Pharmaceuticals Reports Improvement in “Brain Fog,” in..
3/07/202408:37GLOBENew to The Street Announces TV Episode 560 with its Five..
3/07/202407:06EDGAR2Form 8-K - Current report
3/07/202407:00GLOBETonix Pharmaceuticals Announces Publication in Psychiatry..
3/06/202416:01EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
3/06/202407:05EDGAR2Form 8-K - Current report
3/06/202407:00GLOBETonix Pharmaceuticals Selects EVERSANA® to Support Launch..
3/05/202407:05EDGAR2Form 8-K - Current report
3/05/202407:00GLOBETonix Pharmaceuticals Announces Translation of Preclinical..
2/29/202416:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/29/202416:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/29/202416:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/29/202416:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/29/202407:00GLOBETonix Pharmaceuticals Announces Presentation at The 6th..
2/28/202407:06EDGAR2Form 8-K - Current report
2/28/202407:00GLOBETonix Pharmaceuticals Completes Clinical Stage of Phase 1..
2/27/202407:07EDGAR2Form 8-K - Current report
2/27/202407:00GLOBETonix Pharmaceuticals Announces Positive Results from..
2/23/202408:30GLOBENew to The Street Announces Line-up of its Corporate..
2/20/202407:00GLOBETonix Pharmaceuticals to Participate in the 2024 BIO CEO &..
2/16/202408:30GLOBENew to The Street Airs Episode 556 Featuring Five Corporate..
2/15/202416:02EDGAR2Form 8-K - Current report
2/14/202414:56EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2/14/202407:00GLOBETonix Pharmaceuticals Hosted KOL Webinar on Positive Phase 3..
2/13/202407:05EDGAR2Form 8-K - Current report
2/13/202407:00GLOBETonix Pharmaceuticals Announces Engagement of Rho as CRO to..
2/12/202407:00GLOBETonix Pharmaceuticals Announces FDA IND Clearance for DoD..
2/12/202406:06EDGAR2Form 8-K - Current report
1/31/202406:05EDGAR2Form 8-K - Current report
1/31/202406:00GLOBETonix Pharmaceuticals Announces Research Indicating..
1/29/202406:00EDGAR2Form 8-K - Current report
1/29/202406:00GLOBETonix Pharmaceuticals Announces Conditional Acceptance of..
1/25/202415:08EDGAR2Form 8-K - Current report
1/25/202406:00GLOBETonix Pharmaceuticals Announces KOL Webinar to Discuss..
1/19/202415:31EDGAR2Form 8-K - Current report
1/11/202415:53EDGAR2Form SC 13G - Statement of acquisition of beneficial..
1/09/202406:00GLOBETonix Pharmaceuticals Presents Additional Data Highlighting..
1/08/202416:07EDGAR2Form 8-K - Current report
1/08/202415:33EDGAR2Form DEF 14A - Other definitive proxy statements
1/03/202415:23EDGAR2Form SC 13G - Statement of acquisition of beneficial..
1/03/202406:00GLOBETonix Pharmaceuticals to Present at Two Upcoming Investor..

Your Recent History

Delayed Upgrade Clock